Ocrevus Zunovo now approved in US to treat relapsing MS, PPMS
The FDA approved Ocrevus Zunovo, a subcutaneous formulation of Ocrevus, for adults with relapsing forms of MS and PPMS
0 Comments
Ocrevus Zunovo now approved in US to treat relapsing MS, PPMS
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed